Related Experiment Video
Updated: Aug 12, 2025

08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
9.1K
T1 /T2 ratio from 3T MRI improves multiple sclerosis cortical lesion contrast
Abigail R Manning1, Erin S Beck2,3, Matthew K Schindler4
1Penn Statistics in Imaging and Visualization Center, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Summary
The T1/T2 signal intensity ratio effectively detects cortical lesions in multiple sclerosis (MS) using standard MRI. This method enhances accessibility for lesion detection in research and clinical practice.
Area of Science:
- Neuroimaging
- Radiology
- Neurology
Background:
- Cortical demyelinated lesions are common in multiple sclerosis (MS) and linked to disability.
- Current sensitive MRI methods for cortical lesions are not routinely available.
- There is a need for accessible MRI techniques for cortical lesion detection.
Purpose of the Study:
- To evaluate the sensitivity of the T1-weighted/T2-weighted (T1/T2) signal intensity ratio for detecting focal cortical lesions.
- To compare the T1/T2 ratio's sensitivity with other high-field MRI methods.
Main Methods:
- Analyzed 3-Tesla (3T) and 7-Tesla (7T) MRI data from 10 MS patients.
- Calculated T1/T2 images by dividing 3T T1-weighted (T1w) by 3T T2-weighted (T2w) fluid-attenuated inversion recovery images.
- Assessed 614 cortical lesions identified on 7T images using registered 3T sequences, including T1/T2, T1w, T2w, and IR-SWIET.
Main Results:
- T1/T2 images showed significantly higher contrast between lesional and non-lesional cortical signal intensity (median ratio 1.29) compared to T1w (1.01), T2w (1.17), and IR-SWIET (1.21).
- The observed differences were statistically significant (p < .002 for T1w and T2w, p < .03 for IR-SWIET).
Conclusions:
- T1/T2 ratio imaging is sensitive for detecting cortical lesions in MS.
- Incorporating T1/T2 ratio analysis can improve the accessibility of cortical lesion detection in both research and clinical settings.

